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Abstract
Background: In 2006, the Centers for Disease Control and Prevention (CDC) recommended three changes to HIV
testing methods in US healthcare settings: (1) an opt-out approach, (2) removal of separate signed consent, and (3)
optional HIV prevention counseling. These recommendations led to a public debate about their moral
acceptability.
Methods: We interviewed 25 members from the fields of US HIV advocacy, care, policy, and research about the
ethical merits and demerits of the three changes to HIV testing methods. We performed a qualitative analysis of
the participant responses in the interviews and summarized the major themes.
Results: In general, arguments in favor of the methods were based upon their ultimate contribution to increasing
HIV testing and permitting the consequent benefits of identifying those who are HIV infected and linking them to
further care.
Conclusions: The prevailing theme of ethical concern focused on suspicions that the methods might not be
properly implemented, and that further safeguards might be needed.
Background
The 2006 US Centers for Disease Control and Preven-
tion (CDC) recommendations for HIV testing in health-
care settings contain three distinct changes to HIV
testing methods from prior recommendations designed
to streamline and encourage widespread testing: (1) use
of an opt-out HIV approach to introduce HIV screening
and diagnostic testing to patients, (2) use of the general
medical consent for care instead of separate signed con-
sent for HIV testing, and (3) removal of a requirement
to conduct HIV prevention counseling at the time of
HIV testing [1]. The 2006 CDC recommendations
received a mixed and heated public reaction from acade-
micians, advocates, clinicians, government officials, and
researchers [2-34]. Some offered moral praise, others
moral condemnation.
On the one hand, some opponents cited the possibility
for costs or bad consequences that might follow imple-
mentation of the recommendations, while some suppor-
ters cited the potential for good consequences. On the
other hand, some opponents claimed that implementa-
tion of the recommendations might violate patients’
rights, while some supporters denied this. A review of
the literature on the moral evaluation of the recommen-
dations showed that commentators singled out harms or
benefits without balancing the set of harms and the set
of benefits [35]. However, to identify a possible advan-
tage to the recommendations is not to justify them.
Similarly, to identify a possible disadvantage or a moral
concern about the recommendations is not to justify
their rejection.
The objective of this research was to obtain a more
systematic, balanced, and in-depth evaluation of the
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debate. We conducted qualitative interviews with acade-
micians, members of advocacy groups, clinicians, policy-
makers, and researchers who had voiced their opinions
in the media and professional and lay literature in an
attempt to elicit from them a systematic ethical analysis
of the CDC recommendations. First, we asked respon-
dents to consider the potential benefits and the possible
risks or harms posed by the revised HIV testing strate-
gies. Second, we asked respondents whether in their
view each recommendation fulfilled or violated moral
responsibilities to patients. Third, we asked respondents
if they thought each recommendation was respectful or
a violation of patient rights. We performed a qualitative
analysis of these participant responses and provide in
this manuscript an accounting of the predominant
themes. Our aim was to inform the continuing debate
on the implementation of the three CDC-recommended
HIV testing methods, especially in light of CDC’sp l a n
to release new recommendations for HIV testing in
non-healthcare settings [36]. It might be true that the
2006 CDC HIV testing recommendations can be accep-
table to all parties with minor modifications. However,
this conclusion can only be reached after the detail and
nuances of the ethical arguments—both for and
against—are explored in a balanced and systematic
fashion.
Methods
Study design
This manuscript reports on a qualitative analysis of
responses to semi-structured interviews of 25 members
from the fields of US HIV advocacy, clinical or social
care, policy, or research who had commented on the
2006 CDC HIV testing recommendations in the media
or lay or professional literature. The authors’ institu-
tional review board approved this study.
Study participant population
In August 2007, we performed a search of MEDLINE,
Philosopher’s Index, SocIndex, the internet, and medical
and public health journal websites for all articles, com-
mentaries, editorials, press releases, publications,
research, statements, etc. about the 2006 CDC HIV test-
ing recommendations [35]. From this search, 164 docu-
ments or websites met this criterion. From these, 55
authors or persons quoted were identified, and conse-
quently formed the group of potential study participants.
US government officials were excluded as potential
study participants because of potential conflicts of inter-
est from their criticizing or praising the CDC
recommendations.
An investigator who did not conduct the semi-struc-
tured interviews sorted the 55 potential study
participants first by whether or not they, according to
their comments, supported or did not support the CDC
revised recommendations, and second by their primary
occupation. This sorting yielded five strata of partici-
pants: supportive advocates (n = 11), concerned advo-
cates (n = 11), supportive academicians/clinicians/
researchers (n = 15), concerned academicians/clinicians/
researchers (n = 9), and government (non-federal) offi-
cials (n = 9). Using these strata, a list of potential parti-
cipants was generated.
In accordance with recommendations for conducting
qualitative research, we chose an a priori sample size of
25 participants (five from each of the five strata)
[37-39]. A research assistant, who was not involved in
the interviewing process, contacted and invited potential
participants by email, letter, and telephone to participate
in a telephone interview. When extending the invitations
to potential participants, the research assistant
attempted to achieve a gender-balanced and geographi-
cally-diverse participant sample. Invitations were
extended to potential participants until each stratum
was filled with completed interviews. No incentives were
provided to participants.
Survey development
The study authors developed a brief survey for the semi-
structured interviews. The survey contained questions
about three recommended changes to HIV testing meth-
ods germane to this analysis: (1) using an opt-out
approach to HIV testing, (2) replacing separate signed
consent with general medical consent for HIV testing,
and (3) making HIV prevention/risk reduction counsel-
ing optional instead of mandatory (or uncoupling pre-
vention/risk counseling from testing). For each of these
three topic areas, the survey contained open-ended
questions that asked respondents for their opinions on
the topics according to four ethical domains: (1) the
benefits of the change in HIV testing methods; (2) the
r i s k so rh a r m so ft h ec h a n g e ;( 3 )h o wt h ec h a n g ei n
testing methods fulfills or violates ethical responsibilities
of a health care provider to administer appropriate med-
ical care to patients; and (4) how the change in testing
methods respects or violates patient rights. By respecting
or violating patient rights, we asked participants to con-
sider how the ethical domain under discussion allow
patients to receive appropriate health care yet still pro-
tect their civil liberties to choose which medical prac-
tices will be performed on them. These four ethical
domains were chosen by our multidisciplinary group of
investigators (from the fields of clinical medicine, com-
munity health, epidemiology, philosophy-bioethics, and
survey research methodology) from a review of the 164
documents and websites yielded by the literature
searches. These four domains reflect the most common
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quentialist and rights approaches. The survey used was
informed by the two distinct kinds of moral frameworks
prevalent in the expressed responses to the CDC recom-
mendations: a consequentialist framework and a rights
framework. Of the four familiar principles of bioethics
beneficence and non-maleficence are thought to be
grounded in a consequentialist framework, while duties
to respect autonomy and duties of justice are often cor-
related with a rights-based approach to morality [40]. A
copy of the survey relevant to the analysis is provided
with the manuscript.
Survey administration
Participants received a copy of the 2006 CDC HIV test-
ing recommendations and a brief synopsis of the study
and study topics prior to the telephone interviews. Two
of the study authors conducted the interviews; each
author conducted approximately half of the interviews.
The interviewers were blinded to participant strata and
participants’ previous comments in the lay and medical
literature. All interviews were conducted via telephone
from October 2007 through August 2008.
At the start of each interview, each participant was
provided with a description of the nature of the study,
the topics under discussion, the questions that would be
asked, and definitions of any terms used in the inter-
views. Participants were asked to confine their responses
to ethical considerations about each HIV testing
method, as opposed to their practical implementation.
Participants were prompted as necessary by the inter-
viewers to focus their answers on the specific HIV test-
ing method under discussion, and reminded to avoid
commenting on the remaining HIV testing methods or
the recommendations as a whole. Participants giving
short answers to the questions were prompted to elabo-
rate. Interviewers did not otherwise provide any com-
mentary or feedback to the participants. All interviews
were audio-recorded and later transcribed and de-identi-
fied by a research assistant who was not involved in the
interviews.
Analysis
A qualitative content analysis was performed on the de-
identified transcripts without regard to participant
strata. A quantitative analysis of the responses was not
performed, due to the sample size chosen, methods of
the survey, purposive stratification of respondents, and
goals of the planned analysis. The transcribed survey
responses were reviewed and coded by the two inter-
viewers. The two interviewers identified themes, sub-
themes, and sub-sub-themes implicit in the participant
responses. Two secondary reviewers, who had not con-
ducted the interviewers, independently reviewed
separate random samples of 50% of the transcripts for
accuracy and thoroughness of the data extraction and
selection of themes, sub-themes, and sub-sub-themes.
Afterwards, the primary and secondary reviewers dis-
cussed their findings; inconsistencies were discussed and
reconciled.
Results and Discussion
Overarching and recurring themes and overall
observations
A common overarching theme that permeated the
interviews was that any ethical considerations of the
merits or demerits of the HIV testing methods depend
heavily on how they will be implemented. As one par-
ticipant said, “the devil is in the details.” Many partici-
pants stated that if the HIV testing methods were
implemented in a fashion that patients were aware
they were being tested, had the opportunity to refuse
testing, were given adequate pre-test information to
make an informed decision about being tested, and
had an opportunity to engage in further discussion
with their healthcare provider, then the testing meth-
ods fulfilled ethical responsibilities to patients and
respected patient rights. Conversely, if the HIV testing
methods were implemented in a way that patients
were being tested without their knowledge, or without
consent, or without knowing the reasons to be tested
and the consequences of being tested (and the conse-
quences of the test results), or patients were not given
an opportunity to discuss the test further with their
medical provider, then the HIV testing methods would
not fulfill ethical responsibilities to patients and vio-
lated patients’ rights. As expressed by one participant
in regards to using the opt-out approach, “It depends,
and this is actually one of the biggest ambiguities in
the recommendations. I think as a practical manner,
opt-out testing in and of itself does not necessarily vio-
late patients’ rights. I think it heightens the risk for
patients to have their rights violated, but I do believe
that opt-out testing can be conducted ethically and in
a way that protects patients decision-making and
informed consent rights, although...I think there is a
heightened risk that those protections won’to c c u r . ”
Another recurring theme was that many participants
viewed the HIV testing methods as a set that could be
implemented only as a bundle, as opposed to individual
testing methods that could be used individually or
jointly as needed. This perspective is understandable
given the intent of CDC that these methods be imple-
mented as a whole. As a consequence of this view,
respondents who voiced objections to one of the three
testing methods sometimes would conclude that another
method or the entire set of CDC’s recommendations
was morally problematic. This phenomenon was evident
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concerns for each of the three HIV testing methods.
Participants also expressed different underlying opi-
nions -which were reflected in their responses to the
questions- as to whether or not HIV testing ought to be
treated differently than testing for other medical condi-
tions. Those participants who believed that HIV testing
should be treated differently than other types of medical
tests generally believed that more safeguards should be
administered than which the CDC testing methods
recommend. As one participant commented, “You’re
doing a utilitarian calculus, which goes against patient
autonomy in favor of trying to identify as many HIV
positive patients as possible, and that creates mistrust in
the patient-physician relationship.” On the other hand,
those participants who believed that testing for HIV
should be treated similar to testing for other treatable
medical conditions generally believed that additional
safeguards would only impede patients from receiving
what they viewed to be a potentially lifesaving screening
exam. One participant said, “I think it fulfills our ethical
responsibility to look for a disease that is ultimately
treatable and treatable well if you find it early and
devastating if it is missed.”
Opt-out approach to HIV testing (Table 1)
Benefits of the opt-out approach
The benefits of the opt-out approach can be summar-
ized along three main themes: opt-out testing (1)
improves the HIV testing process by overcoming bar-
riers to testing through making HIV testing more con-
venient for the patients when receiving other types of
medical care; making HIV testing more of a standard
part of medical care; enabling testing in patients who
otherwise might be reluctant to broach the topic of HIV
testing; and streamlining the HIV testing process, which
makes it easier for providers to introduce HIV testing
and routinize HIV screening; (2) has beneficial conse-
quences to individuals, public health, and society by
allowing more people to know their status, access life-
saving treatment, and protect loved ones from society;
by permitting HIV-infected individuals to learn their
status earlier in the disease course, which benefits the
individual and helps reduce transmission; and by
decreasing stigma and HIV exceptionalism; and (3) has
beneficial downstream consequences, such as increasing
the number of people who know their status, giving
HIV-infected patients an opportunity to start lifesaving
antiretroviral therapy earlier in their disease course, and
Table 1 Themes of the opt-out approach to HIV testing
Benefits Risks or Harms
Opt-out HIV testing...
Theme: Improves the testing process
Sub-theme: Streamlines the testing process
Sub-theme: Overcomes barriers
Sub-subtheme: Overcomes barriers to the individual
being tested
Sub-subtheme: Overcomes barriers to the provider
conducting testing
Theme: Has beneficial consequences
Sub-theme: Beneficial consequences to public health
Sub-theme: Beneficial consequences to individuals
Sub-theme: Beneficial consequences to society
Theme: Leads to increased testing, which has
beneficial downstream effects
Theme: There are risks and harms inherent in the method or process of opt-out
HIV testing
Theme: There are associated problems when using opt-out HIV testing
Sub-theme: Opt-out testing does not provide adequate consent
Sub-theme: Opt-out testing does not provide adequate pre-test information
Sub-theme: Opt-out testing will lead to increased testing, which can lead to an
increased number of false positives or testing people who do not want to be
tested
Theme: There are conditions or situations when opt-out HIV testing presents
harms or risks
How does opt-out HIV testing
fulfill responsibilities to patients?
Opt-out HIV testing...
Theme: Leads to increased HIV testing, which has
downstream effects
Theme: Promotes HIV screening in clinicians
Theme: Changes a paradigm of HIV testing
Theme: Leads to increased testing, which has
downstream effects
Theme: Promotes patient health
Theme: Overcomes patient barriers to testing
How does opt-out HIV testing
violate responsibilities to patients?
Opt-out HIV testing...
Theme: Opt-out testing does not allow for adequate information delivery
Theme: Opt-out testing changes the beneficiary of testing from the patient to
public health or society
Theme: Opt-out testing negatively affects patient trust
How does opt-out HIV testing
respect patients’ rights?
Opt-out HIV testing...
Theme: Provides an adequate process for patients to
refuse testing
Theme: Leads to increased testing, which has
positive downstream affects on individuals
Theme: Serves individuals and pubic health needs
How does opt-out HIV testing
violate patients’ rights?
Opt-out HIV testing...
Theme: Will likely be poorly implemented, which will violate patients’ rights
Theme: Does not provide for an adequate process for HIV testing
Theme: Compromises individual patient needs
Theme: Limits patients’ options to make their own decisions
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protect others.
Risks or harms of the opt-out approach
For the risks or harms for the opt-out approach, the
first theme centered on concerns inherent in the
method or process of the opt-out approach, such that
test recipients would not understand that they are being
tested for HIV, that the opt-out approach is by its nat-
ure is coercive by limiting patient options and decision-
making, and that the opt-out approach is not patient
centered. Respondents were also concerned that the
opt-out approach must be performed with no separate
signed consent for HIV testing. Therefore, the opt-out
approach limits the consent process and that patients
might be tested with limited or no informed consent. In
addition, some respondents were concerned that the
opt-out approach might also be practiced with limited
or no pre-test information. The second theme con-
cerned perceived associated problems and negative
downstream consequences of the opt-out approach, par-
ticularly related to increased testing. Examples cited
included the problems of initiating, securing and follow-
ing through with referrals for treatment among patients
diagnosed with an HIV infection who were not psycho-
logically or emotionally prepared for their results or
who may not have the resources to find medical care,
and the problems associated with false-positive test
results. The third theme entailed specific conditions or
situations where the opt-out HIV approach might be
practiced in an unethical fashion. For example, vulner-
able populations - such as those with lower health lit-
eracy, those who do not speak English, or intoxicated
patients - might not be fully aware they are being tested.
One respondent stated with regards to those individuals
w h om a yn o tu n d e r s t a n dt h a tt h e ya r eb e i n gt e s t e d ,
“There are issues around language barriers, people who
may be under some chemical influence, people who are
not in a state of being ready to respond to what is being
o f f e r e dt ot h e ma n dn o tr e a l l yu n d e r s t a n d i n gw h a ti s
happening in the health care setting...” Furthermore, in
busy clinical settings, the opt-out approach might give
the clinician an excuse to rush the procedure such that
patients do not have an opportunity to decline testing.
Finally, patients might feel that saying no to their clini-
cian would negatively impact their relationship with
their clinician.
Fulfilling responsibilities to patients and respecting patients
rights with the opt-out approach
In terms of fulfilling ethical responsibilities to patients
and respecting patient rights, the themes included a
view that the opt-out approach was a means of promot-
ing and enabling clinicians to perform HIV testing
through routinizing the testing process and reducing the
barriers associated with HIV testing, which further
enables clinicians to promote the health of their
patients. Similarly, the opt-out approach was viewed as
a way to enable patients to be tested who would other-
wise be reluctant to ask for HIV testing, thereby giving
individuals an opportunity to improve their health.
Some participants stated that the opt-out approach
changes the paradigm of HIV testing from a “special” or
“scary” test to a routine preventive health measure and
reduced HIV exceptionalism. Some stated that the opt-
out approach respected patients’ rights because it pro-
vided an adequate process for patients to refuse testing
and gave them an opportunity to gain access to a bene-
ficial test.
Violating responsibilities to patients and patients’ rights
with the opt-out approach
The opt-out approach was viewed by some respondents
as violating responsibilities to patients because it might
shift the beneficiary of testing from the individual to
society. Therefore, the opt-out approach could create a
barrier between the patient and provider and negatively
affect patient trust. The opt-out approach was viewed as
not providing adequate delivery of information to
patients, especially in regards to the fact that they were
b e i n gt e s t e df o rH I V ,a n dt h a tt h er i s k sa n db e n e f i t so f
HIV testing were not adequately conveyed, particularly
for special populations, such those who speak other lan-
guages, are developmentally disabled, intoxicated, etc.
Some respondents also commented that the opt-out
approach would be poorly implemented, and conse-
quently would not permit adequate pretest information
to be delivered or provide opportunities for patients to
decline testing. Finally, the opt-out approach was viewed
as a means of violating patients’ rights because the
approach inherently limits patients’ options to make
their own decisions, and therefore they will not have a
true opportunity to decline testing.
Removing the separate, signed consent requirement (Table
2)
Some respondents thought the moral acceptability of the
removal of the requirement for a separate signed con-
sent was conditional on a number of factors. No sepa-
rate signed consent was often considered ethical if the
clinician ensured that patients were aware that they
w e r eb e i n gt e s t e df o rH I V ,a n di ft h e yp r o v i d e do p p o r -
tunity for discussion. Some respondents further specified
that no separate signed consent would be ethical if the
patient provided verbal consent for testing. Others
thought no separate signed consent for HIV testing was
necessary if the general consent document made explicit
mention of HIV testing.
Benefits of removing the separate signed consent
requirement
The first theme regarding the benefits of removing the
separate signed consent requirement was that no
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cess by eliminating a cumbersome consent process and
decreasing the onerous paperwork associated with HIV
testing. The second theme was that the removal of sepa-
rate signed consent positively affects the perception of
HIV and HIV testing by making HIV testing seem to be
a standard part of medical care, reducing the impression
that testing for HIV is more dangerous than testing for
other treatable medical conditions, destigmatizing HIV,
and reducing the impression to patients that they are
being profiled or segregated when performing HIV test-
ing. As one respondent stated, “not requiring additional
consent would mean that everyone is eligible to receive
an HIV test without any additional burden of obtaining
any separate consent for HIV testing. So again, it nor-
malizes the testing and makes it similar to other types
of medical testing that is done in a healthcare setting
such as cholesterol screening, such as cancer screening.”
The third theme was that separate signed consent
would increase the number of patients tested for HIV
and, therefore, would have positive downstream conse-
quences, as discussed previously. The fourth theme
underscored the belief that HIV testing is a very power-
ful tool to help individuals and populations, but that in
its current form is not being fully utilized. By removing
the cumbersome consent process and paperwork, clini-
cians will be more apt to conduct HIV testing and
incorporate HIV testing into standard medical care. In
addition, removal of separate signed consent facilitates
testing of those patients who do not fully understand
the benefits of HIV testing.
Risks or harms of removing the separate signed consent
requirement
The first of three themes on the risks of harms of
removing the separate signedc o n s e n tr e q u i r e m e n tw a s
that a separate signed consent for HIV testing serves as
a necessary safeguard, which ensures that patients were
only being tested with knowledge and consent. Some
participants were concerned that no separate signed
consent would lead to a passive or cavalier disregard for
the consent process, loss of legal protections for
patients, inadequate assessment of a patient’s compre-
hension that they are being tested, inadequate transfer
of information, and lack of truly informed consent.
Some respondents also stated that absence of a separate
signed consent might be particularly harmful for vulner-
able populations and for those who might not be pre-
pared for the potential negative consequences - such as
Table 2 Themes of no separate signed consent
Benefits Risks or Harms
Theme: Leads to better utilization of HIV testing
Theme: Positively affects the HIV testing process
Sub-theme: Streamlines
Sub-theme: Overcomes barriers
Theme: Positively affects the perception of HIV and HIV testing
Theme: Leads to increased testing, which has positive downstream
effects
Theme: When specific signed consent is eliminated there is a
loss of a safeguard to HIV testing
Sub-theme: Inadequate transfer of information
Sub-theme: Lack of truly informed consent
Sub-subtheme: May bring harm to specific populations
Sub-subtheme: May lead to negative downstream
consequences
Sub-theme: Passivity in the consent process
Sub-theme: Loss of legal protection for providers
Theme: No specific signed consent harms the trust patients
have in their providers and the medicals system
Theme: No specific signed consent de-emphasizes individual
healthcare needs
How does no separate signed consent fulfill responsibilities to patients?
Theme: General consent for medical care might be considered an
equivalent consent mechanism to separate signed consent
Theme: Reduces barriers to HIV testing
Theme: Leads to increased testing, which has positive downstream
effects
Theme: “Mainstreams” HIV testing
Theme: Improves the HIV testing experience for patients
How does no separate signed consent violate responsibilities to
patients?
Theme: Does not provide for adequate delivery of information
Theme: Does not acknowledge that HIV testing is different
than testing for other diseases
Theme: Negatively affects patient trust
How does no separate signed consent
respect patients’ rights?
Theme: Incorporates a process into good, standard clinical care
Theme: Leads to increased testing, which has positive downstream
effects
Theme: Reduces stigma
How does no separate signed consent
violate patients’ rights?
Theme: Eliminates safeguards in obtaining proper informed
consent
Sub-theme: Does not allow for adequate assessment of patient
comprehension
Sub-theme: Might lead to improper procedures, which could
have negative consequences
Theme: Compromises individual patient needs
Theme: Does not respect patient autonomy
Theme: May lead to paternalistic and poor clinician actions
Theme: May inadvertently reduce patients’ access to care
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infected, transmitting HIV to others, or to their insur-
ance. One respondent stated, “... the social risks of HIV
testing are often not well known, so, individuals who
don’t know their HIV status or may not know the risks
of testing HIV positive to their health care coverage, to
their status as a resident or citizen, to their heightened
risk for work place or housing discrimination, the family
or friend being ostracized, the stigma of discrimination.
Those are real risks that exist today and I believe that
would qualify as needing the definition for informed
consent...” The second theme centered on harm to the
trust patients place in their medical providers and
healthcare systems. Some patients may perceive HIV
testing without separate signed consent as an attempt to
test people without their knowledge or permission.
Therefore, these patients may feel uncomfortable with
the new testing process or might avoid presenting for
healthcare because of a fear of being tested for HIV.
The third theme was that good medical practice focuses
on individual patients’ needs, and that no separate
signed consent de-emphasizes this concept. Some
respondents stated that testing with no separate signed
consent might be perceived as paternalistic and violating
patient autonomy by prioritizing societal over personal
needs.
Fulfilling responsibilities to patients and respecting patients’
rights by removing the separate signed consent
requirement
Several themes emerged on how the removal of the
separate signed consent requirement might fulfill ethical
obligations to patients and respect patents’ rights. Some
participants stated that removal of this requirement ful-
filled responsibilities to patients by reducing barriers,
which had prevented patients from receiving a beneficial
test. Reducing barriers would lead to more testing and
the positive downstream effects of increased testing.
Some participants also stated that eliminating separate
signed consent also fulfilled responsibilities to patients
because it “mainstreamed” HIV testing, making it simi-
lar to other types of medical tests and more feasible to
include HIV testing in a routine battery of tests. Elimi-
nating separate signed consent was also said to improve
the HIV testing experience for patients, both by “main-
streaming” HIV testing and by making the HIV testing
process less onerous. Some participants stated that no
written consent respected patients’ rights in that it facili-
tated good, standard clinical care for patients.
Violating responsibilities to patients and patients’ rights by
removing the separate signed consent requirement
In terms of how removal of the separate signed consent
requirement might violate patients’ rights, the themes
involved concerns of the elimination of a necessary safe-
guard in HIV testing and an assessment of patient
comprehension. Some participants commented that the
intent of eliminating separate signed consent is to avoid
an active discussion about HIV testing with patients,
which undermines patients’ autonomy. Further, the
themes expressed on this topic were under the premise
that if or when patients are tested without their knowl-
edge or permission, this action would violate responsi-
bilities to patients and patients’ rights, might erode
patients’ confidence in their healthcare providers, and
compromise patient autonomy and individual patients’
needs. This lack of confidence might further dissuade
patients - especially those at highest risk - from seeking
medical attention.
Uncoupling HIV prevention counseling from HIV testing
(Table 3)
Benefits of uncoupling HIV prevention counseling from HIV
testing
The benefits or ethical justifications for uncoupling HIV
prevention counseling from HIV testing were grouped
into the following themes. One theme was that this
uncoupling would streamline the HIV testing process by
removing a step that might not be necessary in all cir-
cumstances. Another theme that emerged was that
uncoupling HIV counseling would increase the number
of individuals tested for HIV and, therefore, has impor-
tant downstream consequences, as discussed previously.
Another theme was that this uncoupling utilizes
resources more efficiently at the time of HIV testing,
especially for low-risk patients, repeat testers, and those
knowledgeable about HIV; and reduces the need for
training for prevention counseling and the costs of test-
ing, and was a better use of limited staff. With fewer
resources needed, healthcare providers could expand
access to HIV testing. Another theme which emerged
was that uncoupling HIV prevention counseling deregu-
lates HIV testing. Respondents stated that uncoupling
removes a requirement that is ignored anyway; permits
clinicians to individualize counseling needs for patients;
and, protects patients’ right to privacy by not making
them divulge information about their risk behaviors.
The final theme was that uncoupling makes HIV testing
similar to other types of medical tests which improves
and destigmatizes the perception of HIV and HIV
testing.
Risks or harms of uncoupling HIV prevention counseling
from HIV testing
The first theme of the risks or harms of uncoupling pre-
vention counseling was that this action fails to address
patients’ needs. Several respondents stated that HIV
testing is an ideal “teachable moment” to perform pre-
vention counseling, that counseling was a crucial part of
the HIV testing process, and discourages good clinical
practice. Some expressed concerns that uncoupling
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behaviors. Some respondents expressed beliefs that if
prevention counseling were optional, risk assessments
might never be performed; and those patients who
would benefit from it might not be identified. The sec-
ond theme underscored the perspective that all three
HIV testing strategies - opt-out testing, no separate
signed consent, and uncoupled prevention counseling -
are linked and interdependent. As such, mandatory pre-
vention counseling at the time of testing ensures that
patients are educated about HIV testing and understand
the consequences of the test. Uncoupling this compo-
nent removes another safeguard. The final theme was
that HIV is different from other medical conditions and
deserves to be treated exceptionally. Therefore, HIV
testing may require additional counseling that other
medical conditions do not.
Fulfilling responsibilities to patients and respecting patients
rights by uncoupling HIV prevention counseling from HIV
testing
The major theme regarding fulfilling responsibilities to
patients by uncoupling HIV prevention counseling from
HIV testing was that this strategy expands access to and
deregulates HIV testing. These actions would then lead
to increased HIV testing, which has downstream bene-
fits to patients, as discussed previously. Participants
believed that uncoupled prevention counseling respects
patients’ rights because, by not requiring patients to
divulge their risk taking behaviors in order to get tested
for HIV, it respected patients’ privacy and autonomy.
Violating responsibilities to patients and patients rights by
uncoupling HIV prevention counseling from HIV testing
In terms of violating responsibilities to patients and
patients’ rights, one major theme underscored a belief in
the value of the “teachable moment” to counsel patients
on risk taking behaviors that would be lost if the uncou-
pling strategy were used. In addition, uncoupling might
violate patients’ rights by limiting their access to better
health care. Some participants envisioned that clinicians
would cease to offer prevention counseling to even the
patients most in need.
Several respondents stated that there were situations
under which prevention counseling did not need to be
coupled with HIV testing, although most added that
some degree of information or counseling should be
available to patients as deemed appropriate. As one
respondent said, “... for some patients who are again
very experienced with HIV testing, recognize ... the
methods of transmission, and are coming in for regular
HIV screening they may not need any kind of preven-
tion counseling. For folks who are who are less familiar
with HIV testing, in particular less familiar with HIV
itself, I think that their rights would be better fulfilled
by giving them more information and counseling at the
time of testing.” Some also noted that the uncoupling of
prevention counseling from HIV testing was an “ethical
Table 3 Themes of uncoupling prevention counseling from HIV testing
Benefits Risks or Harms
Theme: Positively affects perception of HIV and HIV testing
Theme: Expands access to HIV testing
Theme: Utilizes resources more efficiently
Theme: Positively affects the HIV testing process
Sub-theme: Streamlines
Sub-theme: Overcomes barriers
Theme: Deregulates HIV testing process
Sub-theme: Benefits patients
Sub-theme: Benefits providers
Theme: Leads to increased testing, which has positive
downstream effects
Theme: Loss of educational opportunity
Theme: Negative effects on risk-taking behaviors
Theme: Discourages good clinical practice
Theme: Fails to address patient needs
Theme: Deleteriously affects other elements in the HIV testing process
How does uncoupled prevention counseling fulfill
responsibilities to patients?
Theme: Expands access to HIV testing
Theme: Deregulates HIV testing
Theme: Leads to increased testing, which has positive
downstream effects
How does uncoupled prevention counseling violate responsibilities to
patients?
Theme: Leads to a loss of an educational opportunity
Theme: Does not acknowledge that HIV testing is different than testing
for other diseases
Theme: May have negative effects on risk-taking behavior
How does uncoupled prevention counseling
respect patients’ rights?
Theme: Protects patients’ right to privacy
Theme: Respects patient autonomy
Theme: Respects individual patient needs
Theme: Leads to increased testing, which has positive
downstream effects
Theme: Deregulates HIV testing
How does uncoupled prevention counseling
violate patients’ rights?
Theme: Limits access to medical care
Waxman et al. BMC Medical Ethics 2011, 12:24
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Page 8 of 10trade-off” between testing more people with less coun-
seling vs. testing fewer people with more counseling.
Conclusions
Since the CDC promulgated their 2006 HIV testing
recommendations, stakeholders in the HIV/AIDS advo-
cacy, care, research, and policy have cited both potential
ethical concerns and justifications for the 2006 CDC
recommendations. Some of the concerns are theoretical
and postulated, others possibly based upon the experi-
ence with conducting HIV testing and providing services
to those who are being tested or who are affected by
HIV/AIDS. Equally so, some of the justifications are
based upon research or experience, or might reflect phi-
losophical perspectives on how to best achieve broader
acceptance and utilization of HIV testing. The objective
of this study was not to weigh the merits of these views,
but present them simultaneously, objectively, and with-
out comment. Those who have concerns about the
recommendations may now understand the perspectives
of those who support their implementation, and vice
versa. Perhaps a common ground can be reached that
promotes effective HIV testing that is inline with cur-
rent perspectives on medical and public health ethics.
The task that remains is to, whenever possible, conduct
research to determine which concerns are shown to be
valid when the recommendations are implemented, and
when modifications of the recommendations are needed.
Likewise, if research indicates that the methods are jus-
tified by their end results and concerns are not found,
then implementation can to improve identification of
those who have HIV but are unaware of their infection.
As raised by some respondents, whether or not the
CDC recommendations will be implemented properly is
an open question. The specific concerns highlighted in
the themes uncovered in this investigation indicate areas
where caution might be necessary, suggest topics for
which specific training and explicit safeguards might be
established, and where further research is needed. We
are hopeful that they may be used to instruct those who
implement the testing methods so that they might be
used properly, to motivate the continued expansion of
HIV screening and diagnostic testing, and shape future
policies on HIV testing. We are also hopeful that the
ultimate good intent of the recommendations can be
used as a framework for their implementation and
further helpful dialogues on improving HIV testing
methods.
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